Home » Topics » Regulatory

Regulatory
RSS

Ibandronate reported useful for improving outcome following endoprosthetic implant

July 6, 2000

New combination HCV therapy launched in Germany

July 6, 2000

Sibutramine demonstrates efficacy in urinary incontinence

July 5, 2000

Alcon claims use of AIT-082 and other neurotrophic factor enhancers in ophthalmic disorders

July 5, 2000

TAP withdraws Uprima NDA until further data available

July 5, 2000

Biovail completes development of controlled-release formulation of Celexa

July 5, 2000

Topiramate now claimed effective in schizophrenia

July 4, 2000

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

July 4, 2000

CPMP recommends approval of Caelyx for treatment of advanced ovarian cancer

July 3, 2000

FDA approves Bayer's next-generation hemophilia A treatment

June 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...